Management of Post-Traumatic Joint Pain

Treatment Approach

The American College of Cardiology and other guideline societies recommend starting with acetaminophen up to 3000-4000 mg daily for post-traumatic joint pain, considering 3000 mg limit to minimize hepatotoxicity risk, using scheduled dosing rather than "as needed" for better sustained pain control 2, 3
Acetaminophen is the preferred first-line pharmacologic treatment for musculoskeletal pain, providing comparable pain relief to NSAIDs in many patients with a significantly safer profile, as recommended by the American Geriatrics Society 3
A Dutch randomized trial of 547 patients with minor musculoskeletal trauma demonstrated that acetaminophen is not inferior to NSAIDs like diclofenac for pain relief, with a strength of evidence supporting its use as first-line treatment 4
If acetaminophen provides insufficient relief after 24-48 hours, apply topical NSAIDs (diclofenac gel) to the affected joint before considering oral NSAIDs, as suggested by guideline societies 2, 3
Only prescribe etoricoxib if acetaminophen and topical NSAIDs have failed to provide adequate pain relief, with evidence from the BMJ supporting its use as a third-line treatment 1, 2

The FDA and guideline societies recommend assessing cardiovascular risk factors before prescribing any COX-2 inhibitor, as patients with known cardiovascular disease or risk factors face increased risk of myocardial infarction and stroke 1, 4
If prescribing etoricoxib (or any oral NSAID), you MUST co-prescribe a proton pump inhibitor for gastroprotection, as recommended by the BMJ and other guideline societies 1, 2, 4
Limit etoricoxib to 120 mg once daily for 5-8 days maximum for acute post-traumatic pain, with evidence supporting the use of the lowest effective dose for the shortest duration possible 1, 2
NICE guidelines explicitly recommend considering oral NSAIDs/COX-2 inhibitors only after paracetamol and topical NSAIDs have been tried, with a strength of evidence supporting this approach 1
The American Geriatrics Society recommends paracetamol as first-line with NSAIDs reserved for inadequate response, highlighting the importance of prioritizing safer options first 3